Additional Information
Size: |
100 ug |
Antibody Target: |
CIKS/Act1 |
Target Alternative Name: |
CIKS, ACT1, ACT-1,TRAF3IP2, C6orf4, C6orf5, C6orf6, RAF3-interacting protein 2, Nuclear factor NF-kappa-B activator 1; ACT1; Adaptor protein CIKS; Adapter protein CIKS |
Tagline: |
N/A |
Category: |
CIKS/Act1 |
Host: |
Rabbit |
Antibody Type: |
Polyclonal |
Isotype: |
Rabbit IgG |
Clone: |
N/A |
Species Reactivity: |
N/A |
Immunogen Sequence: |
Synthetic peptide mapping to the N-terminus of human CIKS |
Accession: |
AAG15407 |
Gene ID: |
10758 |
Appearance: |
Colorless liquid |
Concentration: |
0.5 mg/mL |
Formulation: |
100 ug (0.5 mg/ml) affinity purified rabbit anti-CIKS/Act1 polyclonal antibody in phosphate buffered saline (PBS), pH 7.2, containing 30% glycerol, 0.5% BSA, and 0.01% thimerosal. |
Purification: |
Affinity purified |
Application: |
Western blot |
Positive Control: |
N/A |
Application & Usage: |
Western blotting (0.5-4 ug/ml). However, the optimal conditions should be determined individually. The antibody detects the ~63 kDa human CIKS/Act1. Human placenta tissue lysate can be used as a positive control. |
Storage: |
-20°C |
Shipping: |
Gel Pack |
Shelf Life: |
12 months |
Usage: |
For Research Use Only |
Handling: |
The antibody solution should be gently mixed before use. |